港交所陈翊庭，重磅发声！

Group 1 - Hong Kong Exchanges and Clearing is processing over 200 listing applications, with nearly half from technology companies [8][9] - The new stock issuance scale has significantly increased, with total financing reaching HKD 134.5 billion by the end of August, nearly six times higher than the same period in 2024 [8] - The "A+H" listing model has been particularly prominent, accounting for 70% of total financing in the first half of the year, indicating strong momentum between mainland and Hong Kong markets [8] Group 2 - The biotechnology sector has seen a strong rebound, with the Hang Seng Biotechnology Index rising by 4.67% [2] - Notable stocks in the biotechnology sector include 3SBio, which surged by 18.24%, and Kangtai Biological, which rose by 14.53% [2] - The technology sector is also performing well, with Horizon Robotics increasing by 9.12% and Semiconductor Manufacturing International Corporation rising by 4.82% [5] Group 3 - The total amount of refinancing reached HKD 358 billion by the end of August, more than double the new stock market fundraising amount during the same period [9] - Approximately 40% of this refinancing total comes from technology companies, reflecting their active engagement in capital markets [10] - The Hong Kong Stock Exchange has been optimizing its listing system to support the development of technology companies, with 24 biotechnology companies and 12 specialized technology companies currently applying for listings [10]